Skip to main content
. 2021 Mar 4;76(8):e133–e141. doi: 10.1093/gerona/glab060

Table 4.

Models for COVID-19 Inpatient Test Positivity and COVID-19-Related Mortality With Inpatient Test-Confirmed COVID-19: M5 and M6

M5: Age at the Pandemic (March 16, 2020) + Preexisting Diseases or Conditions to March 2020 M6: Age at the Pandemic (March 16, 2020) + Preexisting Diseases or Conditions to March 2020 + PhenoAgeAccel at Baseline
Positive (n = 613) vs Untested or Negative (n = 338 672) Positive Dead (n = 151) vs Positive Alive, Untested or Negative (n = 339 108) Positive (n = 613) vs Untested or Negative (n = 338 672) Positive Dead vs Positive Alive, Untested or Negative (n = 338 108)
Sex* (=male) 1.41 (1.19, 1.66)
p = 6e-05
1.76 (1.24, 2.49)
p = 1.6e-03
1.37 (1.16, 1.62)
p = 2.0e-04
1.66 (1.17, 2.37)
p = 4.6e-03
Ethnicity
 Black 2.59 (1.71, 3.90)
p = 6.1e-06
2.39 (1.00, 5.68)
p = .049
2.56 (1.69, 3.86)
p = 8.1e-06
2.34 (0.98, 5.59)
p = .055
 Other (incl. Asian, Chinese, and Mixed) 1.81 (1.30, 2.50)
p = 3.8e-04
1.38 (0.65, 2.94)
p = .40
1.82 (1.31, 2.52)
p = 3.3e-04
1.42 (0.67, 3.02)
p = .37
Age at the pandemic (per 5 years) 0.95 (0.90, 1.00)
p = .057
1.46 (1.26, 1.69)
p = 3.9e-07
0.95 (0.90, 1.01)
p = .09
1.48 (1.28, 1.71)
p = 1.7e-07
PhenoAgeAccel (per 5 years) 1.10 (1.02, 1.19)
p = .016
1.21 (1.04, 1.40)
p = .011
Dementia (n1 = 60; n2 = 31) 5.56 (4.00, 7.74)
p = 2.5e-24
7.20 (4.37, 11.86)
p = 9.0e-15
5.62 (4.04, 7.82)
p = 1.2e-24
7.35 (4.46, 12.11)
p = 4.7e-15
Type 2 diabetes (n1 = 131; n2 = 52) 1.65 (1.32, 2.05)
p = 9.9e-06
2.04 (1.39, 2.99)
p = 2.6e-04
1.54 (1.23, 1.93)
p = 2.1e-04
1.80 (1.21, 2.67)
p = 3.7e-03
History of pneumonia (n1 = 112; n2 = 41) 2.27 (1.79, 2.89)
p = 1.4e-11
2.28 (1.48, 3.50)
p = 1.7e-04
2.24 (1.76, 2.84)
p = 3.9e-11
2.20 (1.43, 3.39)
p = 3.3e-04
Depression (n1 = 104; n2 = 31) 1.38 (1.10, 1.73)
p = 5.3e-03
1.50 (0.97, 2.31)
p = .07
1.37 (1.09, 1.72)
p = 6.1e-03
1.50 (0.97, 2.32)
p = .068
Atrial fibrillation (n1 = 99; n2 = 36) 1.47 (1.15, 1.88)
p = 2.3e-03
1.29 (0.84, 1.97)
p = .24
1.46 (1.14, 1.87)
p = 2.7e-03
1.27 (0.83, 1.95)
p = .26
Hypertension (n1 = 352; n2 = 118) 1.47 (1.22, 1.77)
p = 6.0e-05
2.22 (1.46, 3.38)
p = 2e-04
1.44 (1.19, 1.74)
p = 1.3e-04
2.15 (1.41, 3.28)
p = 3.5e-04
COPD (n1 = 71; n2 = 29) 1.21 (0.92, 1.61)
p = .18
1.69 (1.06, 2.69)
p = .028
1.18 (0.89, 1.57)
p = .24
1.61 (1.01, 2.57)
p = .047
Chronic kidney disease (n1 = 72; n2 = 29) 1.66 (1.26, 2.19)
p = 3.6e-04
1.65 (1.04, 2.61)
p = .032
1.57 (1.18, 2.08)
p = 1.7e-03
1.48 (0.93, 2.36)
p = .10
Liver disease (n1 = 36; n2 = 6) 1.27 (0.89, 1.81)
p = .19
0.61 (0.26, 1.43)
p = .26
1.25 (0.87, 1.78)
p = .23
0.58 (0.24, 1.37)
p = .21
Rheumatoid arthritis (n1 = 26; n2 = 12) 1.16 (0.77, 1.75)
p = .47
1.60 (0.84, 3.07)
p = .15
1.12 (0.74, 1.68)
p = .60
1.46 (0.76, 2.82)
p = .26
Coronary artery disease (n1 = 133; n2 = 47) 1.03 (0.83, 1.29)
p = .79
0.98 (0.66, 1.44)
p = .90
1.03 (0.82, 1.28)
p = .83
0.96 (0.65, 1.43)
p = .85
Delirium (n1 = 40; n2 = 19) 1.79 (1.21, 2.66)
p = 3.8e-03
1.85 (1.01, 3.38)
p = .045
1.79 (1.21, 2.66)
p = 3.9e-03
1.85 (1.01, 3.39)
p = .045
Stroke (n1 = 30; n2 = 11) 1.41 (0.95, 2.08)
p = .089
1.30 (0.68, 2.49)
p = .43
1.39 (0.94, 2.06)
p = .10
1.26 (0.66, 2.43)
p = .48
Asthma (n1 = 117; n2 = 24) 1.09 (0.88, 1.35)
p = .42
0.71 (0.44, 1.13)
p = .15
1.09 (0.88, 1.35)
p = .45
0.70 (0.44, 1.13)
p = .14
Previous falls/fragile fractures (n1 = 140; n2 = 48) 1.87 (1.50, 2.32)
p = 2.3e-08
1.68 (1.11, 2.54)
p = .014
1.85 (1.49, 2.31)
p = 3.5e-08
1.65 (1.09, 2.50)
p = .018
Osteoarthritis (n1 = 80; n2 = 28) 0.84 (0.65, 1.07)
p = .16
0.89 (0.58, 1.38)
p = .61
0.83 (0.65, 1.07)
p = .15
0.89 (0.58, 1.37)
p = .60

Notes: In bold if p < .05; assessment center results skipped; n1: number of inpatient positives between March 16 and April 27, 2020; n2: number of COVID-19-related deaths following an inpatient positive result between March 16 and April 27, 2020.

*Reference: female.

Reference: White.